Total Filings
243
Unique Marks
238
First Filing
May 5, 1993
Last Filing
Jun 3, 2026
Pending: 24
Registered: 217
Abandoned: 2
Filing Velocity (24 Months)
Aug 2024: 0
Sep 2024: 0
Oct 2024: 0
Nov 2024: 0
Dec 2024: 0
Jan 2025: 0
Feb 2025: 0
Mar 2025: 0
Apr 2025: 0
May 2025: 1
Jun 2025: 0
Jul 2025: 0
Aug 2025: 0
Sep 2025: 46
Oct 2025: 2
Nov 2025: 0
Dec 2025: 43
Jan 2026: 18
Feb 2026: 38
Mar 2026: 23
Apr 2026: 29
May 2026: 24
Jun 2026: 1
Jul 2026: 0
Aug 2024
Jul 2026
Filing Activity by NICE Class
NICE Class Distribution
Trademark Filings
| Mark | Status |
|---|---|
| HUBEKO | Registered |
| MAZVIDA | Registered |
| STREXANDO | Registered |
| WIDNAVO | Registered |
| RALSURMO | Registered |
| COGITO FORGE | Registered |
| RESMOXEO | Registered |
| REZBYU | Registered |
| VIQFORZ | Registered |
| MOVURXLI | Registered |
| MOCIFYDE | Registered |
| FORZUDI | Registered |
| BREMORVU | Registered |
| BYMOCY | Registered |
| VIKTONRU | Registered |
| XYGOLNI | Registered |
| VOKEPNEY | Registered |
| TROBUSQA | Registered |
| TUZEDLO | Registered |
| VELIHAYL | Registered |
| BMOPHORE | Registered |
| BFORSEV | Registered |
| SPEQLI | Registered |
| SOJUNIVY | Registered |
| MOCIFIQ | Registered |
| SIGCIFITI | Registered |
| WELLCOVORIN | Registered |
| BRIDBY | Registered |
| KYFREMLY | Registered |
| DUXFAMLA | Registered |
| CEBKEDLO | Registered |
| INVOUTSO | Registered |
| MAYSHORVA | Registered |
| LIFKEDSO | Registered |
| JESPLIO | Registered |
| JYJOZI | Registered |
| KEDNUVEV | Registered |
| VURPIXAG | Registered |
| VORPIXTO | Registered |
| TAYMZI | Registered |
| TARGNYRVA | Registered |
| CYRSIFI | Registered |
| KIPIIXTA | Registered |
| JYDORY | Registered |
| HUSHIAB | Registered |
| DYSNERVY | Registered |
| FLENEXLYS | Registered |
| AFELQA | Registered |
| ARYOV | Registered |
| AMDULO | Registered |
Community notes
0 notes
Sign in to add a note
Share what you know about Glaxo Group Limited and help the next person researching it.
No notes yet. Be the first to add what you know about Glaxo Group Limited.